Sunday, October 18, 2026

Retail

10 articles

Steak and Ale revival faces 70% failure risk in pattern mirroring global dormant brand collapses

Steak and Ale revival faces 70% failure risk in pattern mirroring global dormant brand collapses

Steak and Ale's 2024 reopening confronts a 70% failure probability after 16 years of closure, facing challenges that bankrupted dormant brand revivals from Howard Johnson's in the US to Wimpy in the UK. The casual dining chain must compete against entrenched rivals while targeting consumers with no memory of its pre-2008 operations across 280 locations.

ViaNews Editorial Team•
Carrefour and JCDecaux deploy retail media network across 179 Spanish sites in 2027 expansion

Carrefour and JCDecaux deploy retail media network across 179 Spanish sites in 2027 expansion

Carrefour, Carmila, Unlimitail, and JCDecaux will launch a retail media network across 179 Spanish locations in January 2027, extending their French model to Spain. The partnership combines JCDecaux's outdoor advertising reach with Carrefour's customer data across 91 shopping centres and 88 outdoor sites. Spain's 575 shopping centres attract 2.4 billion annual visitors, offering immediate scale for the joint venture.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,396 source documents archived
Query this data → isubstrate.com